Enhanced endothelial progenitor cell angiogenic potency, present in early experimental renovascular hypertension, deteriorates with disease duration

Journal of Hypertension

Volumn 29, Issue 10, 2011, Pages 1972-1979

  Zhu, Xiang Yang ^a   Caceres, Victor H Urbieta ^a   Favreau, Frederic D ^a   Krier, James D ^a   Lerman, Amir ^b   Lerman, Lilach O ^a,b  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Angiogenesis; Angiotensin II; Endothelial progenitor cell; Growth factor; Renal hypertension

Indexed keywords

ANGIOTENSIN II; CD34 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CREATININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; RENIN; STROMAL CELL DERIVED FACTOR 1; VALSARTAN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BLOOD VESSEL PARAMETERS; CELL FUNCTION; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DENSITY; DISEASE DURATION; ENDOTHELIAL PROGENITOR CELL; EX VIVO STUDY; EXPERIMENTAL PIG; GLOMERULUS FILTRATION RATE; IN VIVO STUDY; KIDNEY ARTERY STENOSIS; KIDNEY BLOOD FLOW; MEAN ARTERIAL PRESSURE; MICRO-COMPUTED TOMOGRAPHY; MICROVASCULAR DENSITY; MICROVASCULATURE; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RENOVASCULAR HYPERTENSION; ADULT STEM CELL; ANIMAL; BIOLOGICAL MODEL; BLOOD; DISEASE MODEL; ENDOTHELIUM CELL; KIDNEY; KIDNEY CIRCULATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; SWINE; TIME; VASCULARIZATION;

ADULT STEM CELLS; ANIMALS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; GLOMERULAR FILTRATION RATE; HYPERTENSION, RENOVASCULAR; KIDNEY; MODELS, CARDIOVASCULAR; NEOVASCULARIZATION, PHYSIOLOGIC; RENAL CIRCULATION; RENIN; RISK FACTORS; SUS SCROFA; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84856004957     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32834ae611     Document Type: Article

References (34)

1. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89:E1-E7.
2. Imanishi T, Moriwaki C, Hano T, Nishio I. Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. J Hypertens 2005;23:1831-1837. (Pubitemid 41830423)
3. Salguero G, Akin E, Templin C, Kotlarz D, Doerries C, Landmesser U, et al. Renovascular hypertension by two-kidney one-clip enhances endothelial progenitor cell mobilization in a p47phox-dependent manner. J Hypertens 2008;26:257-268.
4. Imanishi T, Hano T, Nishio I. Angiotensin ii potentiates vascular endothelial growth factor-induced proliferation and network formation of endothelial progenitor cells. Hypertens Res 2004;27:101-108. (Pubitemid 38331920)
5. Belgore FM, Blann AD, Li-Saw-Hee FL, Beevers DG, Lip GY. Plasma levels of vascular endothelial growth factor and its soluble receptor (sflt-1) in essential hypertension. Am J Cardiol 2001;87:805-807; A809. (Pubitemid 32209107)
6. Yin T, Ma X, Zhao L, Cheng K, Wang H. Angiotensin ii promotes no production, inhibits apoptosis and enhances adhesion potential of bone marrow-derived endothelial progenitor cells. Cell Res 2008;18:792-799. (Pubitemid 351948226)
7. Imanishi T, Kobayashi K, Kuroi A, Ikejima H, Akasaka T. Pioglitazone inhibits angiotensin ii-induced senescence of endothelial progenitor cell. Hypertens Res 2008;31:757-765. (Pubitemid 351772867)
8. Chade AR, Zhu X, Lavi R, Krier JD, Pislaru S, Simari RD, et al. Endothelial progenitor cells restore renal function in chronic experimental renovascular disease. Circulation 2009;119:547-557.
9. Lerman LO, Nath KA, Rodriguez-Porcel M, Krier JD, Schwartz RS, Napoli C, Romero JC. Increased oxidative stress in experimental renovascular hypertension. Hypertension 2001;37:541-546. (Pubitemid 32199025)
10. Zhu XY, Chade AR, Rodriguez-Porcel M, Bentley MD, Ritman EL, Lerman A, Lerman LO. Cortical microvascular remodeling in the stenotic kidney: Role of increased oxidative stress. Arterioscler Thromb Vasc Biol 2004;24:1854-1859. (Pubitemid 39350303)
11. Zhu XY, Daghini E, Chade AR, Napoli C, Ritman EL, Lerman A, Lerman LO. Simvastatin prevents coronary microvascular remodeling in renovascular hypertensive pigs. J Am Soc Nephrol 2007;18:1209-1217. (Pubitemid 46536907)
12. Chade AR, Zhu XY, Krier JD, Jordan KL, Textor SC, Grande JP, et al. Endothelial progenitor cells homing and renal repair in experimental renovascular disease. Stem Cells 2010;28:1039-1047.
13. Zhu XY, Daghini E, Chade AR, Lavi R, Napoli C, Lerman A, Lerman LO. Disparate effects of simvastatin on angiogenesis during hypoxia and inflammation. Life Sci 2008;83:801-809.
14. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600. (Pubitemid 36204953)
15. Choi JH, Kim KL, Huh W, Kim B, Byun J, Suh W, et al. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 2004;24:1246-1252. (Pubitemid 38880016)
16. Daghini E, Zhu XY, Versari D, Bentley MD, Napoli C, Lerman A, Lerman LO. Antioxidant vitamins induce angiogenesis in the normal pig kidney. Am J Physiol 2007;293:F371-F381. (Pubitemid 47345038)
17. Zhu XY, Chade AR, Krier JD, Daghini E, Lavi R, Guglielmotti A, et al. The chemokine monocyte chemoattractant protein-1 contributes to renal dysfunction in swine renovascular hypertension. J Hypertens 2009;27:2063-2073.
18. Zhu XY, Rodriguez-Porcel M, Bentley MD, Chade AR, Sica V, Napoli C, et al. Antioxidant intervention attenuates myocardial neovascularization in hypercholesterolemia. Circulation 2004;109:2109-2115. (Pubitemid 38620220)
19. Bentley MD, Rodriguez-Porcel M, Lerman A, Sarafov MH, Romero JC, Pelaez LI, et al. Enhanced renal cortical vascularization in experimental hypercholesterolemia. Kidney Int 2002;61:1056-1063. (Pubitemid 34175475)
20. Chade AR, Bentley MD, Zhu X, Rodriguez-Porcel M, Niemeyer S, Amores-Arriaga B, et al. Antioxidant intervention prevents renal neovascularization in hypercholesterolemic pigs. J Am Soc Nephrol 2004;15:1816-1825. (Pubitemid 38822060)
21. Price CM, Colman SM, Kanfer EJ. Persistence of multilineage host haemopoiesis following allogeneic bone marrow transplantation. Br J Haematol 1995;90:465-468.
22. Chade AR, Rodriguez-Porcel M, Grande JP, Zhu X, Sica V, Napoli C, et al. Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis. Arterioscler Thromb Vasc Biol 2003;23:1295-1301. (Pubitemid 36871287)
23. Zhao Q, Ishibashi M, Hiasa K, Tan C, Takeshita A, Egashira K. Essential role of vascular endothelial growth factor in angiotensin ii-induced vascular inflammation and remodeling. Hypertension 2004;44:264-270. (Pubitemid 39172204)
24. Anton L, Merrill DC, Neves LA, Gruver C, Moorefield C, Brosnihan KB. Angiotensin ii and angiotensin-(1-7) decrease sflt1 release in normal but not preeclamptic chorionic villi: an in vitro study. Reprod Biol Endocrinol 2010;8:135-144.
25. Haugen EN, Croatt AJ, Nath KA. Angiotensin ii induces renal oxidant stress in vivo and heme oxygenase-1 in vivo and in vitro. Kidney Int 2000;58:144-152. (Pubitemid 30429859)
26. Cudmore M, Ahmad S, Al-Ani B, Fujisawa T, Coxall H, Chudasama K, et al. Negative regulation of soluble flt-1 and soluble endoglin release by heme oxygenase-1. Circulation 2007;115:1789-1797. (Pubitemid 46648616)
27. Zhu XY, Daghini E, Chade AR, Versari D, Krier JD, Textor KB, et al. Myocardial microvascular function during acute coronary artery stenosis: effect of hypertension and hypercholesterolaemia. Cardiovasc Res 2009;83:371-380.
28. Di Marco GS, Reuter S, Hillebrand U, Amler S, Konig M, Larger E, et al. The soluble vegf receptor sflt1 contributes to endothelial dysfunction in ckd. J Am Soc Nephrol 2009;20:2235-2245.
29. Tamarat R, Silvestre JS, Durie M, Levy BI. Angiotensin ii angiogenic effect in vivo involves vascular endothelial growth factor-and inflammation-related pathways. Lab Invest 2002;82:747-756. (Pubitemid 34633824)
30. Hiasa K, Ishibashi M, Ohtani K, Inoue S, Zhao Q, Kitamoto S, et al. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation 2004;109:2454-2461. (Pubitemid 38679567)
31. Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, Murasawa S, et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003;107:1322-1328. (Pubitemid 36314418)
32. Urbich C, Aicher A, Heeschen C, Dernbach E, Hofmann WK, Zeiher AM, Dimmeler S. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 2005;39:733-742. (Pubitemid 41464410)
33. Fadini GP, Miotto D, Baesso I, Facco M, Miorin M, Tiengo A, et al. Arteriovenous gradient of endothelial progenitor cells across renal artery stenosis. Atherosclerosis 2005;182:189-191. (Pubitemid 41188386)
34. Giannotti G, Doerries C, Mocharla PS, Mueller MF, Bahlmann FH, Horvath T, et al. Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction. Hypertension 2010;55:1389-1397.